Palisade Bio (PALI) FCF Margin Growth (5y) (2016 - 2023)
Powered by 
Analysis
Palisade Bio (PALI) FCF Margin Growth (5y) (2016 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 7.26 Mn |
| Dec 31, 2020 | 9.59 Mn |
| Sep 30, 2020 | 18.69 Mn |
| Jun 30, 2020 | 16.84 Mn |
| Mar 31, 2020 | 13.45 Mn |
| Dec 31, 2019 | -660,207.00 |
| Sep 30, 2019 | -1.33 Mn |
| Jun 30, 2019 | 2.84 Mn |
| Mar 31, 2019 | 189,724.00 |
| Dec 31, 2018 | 3.31 Mn |
| Sep 30, 2018 | 2.77 Mn |
| Jun 30, 2018 | 13.35 Mn |
| Mar 31, 2018 | -7.16 Mn |
| Dec 31, 2017 | 10.02 Mn |
| Sep 30, 2017 | -13.21 Mn |
| Jun 30, 2017 | -13.21 Mn |
| Mar 31, 2017 | -17.61 Mn |
| Dec 31, 2016 | -4.60 Mn |
| Sep 30, 2016 | -17.73 Mn |